The segmental progression of early untreated Parkinson disease: a novel approach to clinical rating
Résumé
To assess the ability of potentially neuroprotective compounds to slow the progression of Parkinson's disease (PD), sensitive rating scales are needed to detect clinically meaningful effects. We evaluated the topographical progression of motor signs in early untreated PD to complement current clinical ratings and enhance the sensitivity to detect disease progression.
Origine : Fichiers produits par l'(les) auteur(s)
Loading...